comparemela.com

Latest Breaking News On - Soleno therapeutics inc - Page 4 : comparemela.com

Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock

Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Brian-ritchie
Piper-sandler
Soleno-therapeutics-inc
Securities-exchange
Company-annual-report-on-form
Guggenheim-securities
Piper-sandler-co
Laidlaw-company-united-kingdom-ltd
Cantor-fitzgerald-co
Exchange-commission

Soleno Therapeutics Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to the Natural History of Prader-Willi Syndrome

REDWOOD CITY, Calif., April 30, 2024 Soleno Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced the.

United-states
Jennifer-miller
Brian-ritchie
Shawn-mccandless
Prader-willi-syndrome-association-united-states
Globenewswire-inc
Research-programs
Securities-exchange
Soleno-therapeutics-inc
Lifesci-advisors
Company-phase
Foundation-for-prader-willi-research

Soleno Therapeutics (SLNO) Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome

Soleno Therapeutics (SLNO) Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Manish-bhatnagar
Drug-administration
Soleno-therapeutics-inc
Soleno-therapeutics
Breakthrough-therapy-designation
Chief-executive-officer
Therapy-designation
With-breakthrough-therapy-designation
Orphan-drug-designation
Fast-track-designation

Soleno Therapeutics Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome (PWS)

Soleno Therapeutics Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome (PWS)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states
Brian-ritchie
Manish-bhatnagar
Soleno-therapeutics-inc
Foundation-for-prader-willi-research
Drug-administration
Lifesci-advisors
Prader-willi-syndrome-association-united-states
Securities-exchange
Diazoxide-choline
Extended-release-tablets
Prader-willi-syndrome
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.